Mirae’s Western expansion

Mirae Asset Financial Group is tapping the Western market experience of biosimilar company Celltrion Inc. (KOSDAQ:068270) to expand its VC investments outside of Asia.

The partners will jointly launch a healthcare fund this month. Each will contribute half of the fund’s W150 billion ($135 million), according to Mirae’s Hyun Tae Kim. ...